Jackie Nedell is a long-time Washington journalist but she’s the one making news by going public about suffering from the rare and painful skin condition.
1. Intravenous ertapenem administered for a mean of 13 weeks for patients with hidradenitis suppurativa was associated with improvement in clinical outcomes, inflammatory markers, and patient satisfaction. 2. Larger prospective and randomized clinical trials are needed to further understand the outcomes and optimal dosing/duration of intravenous ertapenem for hidradenitis suppurativa. Evidence Rating Level: 2 (Good)
Bimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
Acelyrin, Inc to Post Q1 2024 Earnings of ($0 86) Per Share, HC Wainwright Forecasts (NASDAQ:SLRN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.